A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

Pfizer

Status and phase: Completed; Phase 3

Conditions: Diabetes Mellitus

Treatments: Drug: Inhaled Insulin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00134147

A2171018

Details and patient eligibility

About

To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents

Sex: All

Ages: 35 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diabetes mellitus Type 2
• Failing two or more oral anti-diabetic agents

Exclusion criteria

• Asthma, COPD
• Smoking

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)